Anti‐Tuberculosis Evaluation and Conformational Study of N‐Acylhydrazones Containing the Thiophene Nucleus. Issue 6 (10th March 2014)
- Record Type:
- Journal Article
- Title:
- Anti‐Tuberculosis Evaluation and Conformational Study of N‐Acylhydrazones Containing the Thiophene Nucleus. Issue 6 (10th March 2014)
- Main Title:
- Anti‐Tuberculosis Evaluation and Conformational Study of N‐Acylhydrazones Containing the Thiophene Nucleus
- Authors:
- Cardoso, Laura N. F.
Bispo, Marcelle L. F.
Kaiser, Carlos R.
Wardell, James L.
Wardell, Solange M. S. V.
Lourenço, Maria C. S.
Bezerra, Flávio A. F. M.
Soares, Rodrigo P. P.
Rocha, Marcele N.
de Souza, Marcus V. N. - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ardp201300417-sec-0001" sec-type="section"> <p>A series of <italic>N</italic>‐acylhydrazonyl‐thienyl derivatives (compounds <bold>2</bold> and <bold>3</bold>), mainly of the type 2‐(aryl‐CHNNHCOCH<sub>2</sub>)‐thiene (<bold>2</bold>: aryl = substituted‐phenyl; <bold>3</bold>: aryl = heteroaryl) were evaluated against <italic>Mycobacterium tuberculosis</italic>. Particularly active compound was <bold>3</bold> (heteroaryl = 5‐nitrothien‐2‐yl or 5‐nitrofuran‐2‐yl) with MIC values of 8.5 and 9.0 μM, respectively. Moderately active compounds were compound <bold>3</bold> (heteroaryl = pyridin‐2‐yl) and compound <bold>2</bold> containing aryl = 2‐ or 4‐hydroxyphenyl groups, with MIC values between 170 and 408 μM. Compound <bold>2</bold> containing OMe, H, F, Cl, Br, CN, and NO<sub>2</sub> substituents and compound <bold>3</bold> (heteroaryl = furan‐2‐yl, thien‐2‐yl, pyrrol‐2‐yl, imidazol‐2‐yl, pyridin‐3‐yl, and pyridin‐4‐yl) were all inactive. Clearly, there is no correlation of activity with the electronic effects of the substituents. The activities suggest different modes of biological action of the compounds having nitro‐heteroaryl groups, on the one hand, and the 2‐hydroxyphenyl or pyridin‐2‐yl substituents, on the other hand. Compounds having 2‐ or 4‐hydroxyphenyl, 2‐hydroxy‐5‐nitrophenyl, or 4‐hydroxy‐3‐chlorophenyl were less cytotoxic than ethambutol. It is important to notice<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ardp201300417-sec-0001" sec-type="section"> <p>A series of <italic>N</italic>‐acylhydrazonyl‐thienyl derivatives (compounds <bold>2</bold> and <bold>3</bold>), mainly of the type 2‐(aryl‐CHNNHCOCH<sub>2</sub>)‐thiene (<bold>2</bold>: aryl = substituted‐phenyl; <bold>3</bold>: aryl = heteroaryl) were evaluated against <italic>Mycobacterium tuberculosis</italic>. Particularly active compound was <bold>3</bold> (heteroaryl = 5‐nitrothien‐2‐yl or 5‐nitrofuran‐2‐yl) with MIC values of 8.5 and 9.0 μM, respectively. Moderately active compounds were compound <bold>3</bold> (heteroaryl = pyridin‐2‐yl) and compound <bold>2</bold> containing aryl = 2‐ or 4‐hydroxyphenyl groups, with MIC values between 170 and 408 μM. Compound <bold>2</bold> containing OMe, H, F, Cl, Br, CN, and NO<sub>2</sub> substituents and compound <bold>3</bold> (heteroaryl = furan‐2‐yl, thien‐2‐yl, pyrrol‐2‐yl, imidazol‐2‐yl, pyridin‐3‐yl, and pyridin‐4‐yl) were all inactive. Clearly, there is no correlation of activity with the electronic effects of the substituents. The activities suggest different modes of biological action of the compounds having nitro‐heteroaryl groups, on the one hand, and the 2‐hydroxyphenyl or pyridin‐2‐yl substituents, on the other hand. Compounds having 2‐ or 4‐hydroxyphenyl, 2‐hydroxy‐5‐nitrophenyl, or 4‐hydroxy‐3‐chlorophenyl were less cytotoxic than ethambutol. It is important to notice that compound <bold>3</bold> (aryl = 5‐NO<sub>2</sub>‐furan‐2‐yl) exhibited a promising therapeutic index (TI = 1093.90), with a value 4.4 less than that of ethambutol. Compounds <bold>2</bold> and <bold>3</bold> exist in DMSO or MeOD solutions as mixtures of <italic>E</italic><sub>C(O)N</sub>/<italic>E</italic><sub>CN</sub> and <italic>Z</italic><sub>C(O)N</sub>/<italic>E</italic><sub>CN</sub> conformers.</p> </sec> </abstract> … (more)
- Is Part Of:
- Archiv der Pharmazie. Volume 347:Issue 6(2014:Jun.)
- Journal:
- Archiv der Pharmazie
- Issue:
- Volume 347:Issue 6(2014:Jun.)
- Issue Display:
- Volume 347, Issue 6 (2014)
- Year:
- 2014
- Volume:
- 347
- Issue:
- 6
- Issue Sort Value:
- 2014-0347-0006-0000
- Page Start:
- 432
- Page End:
- 448
- Publication Date:
- 2014-03-10
- Subjects:
- Pharmaceutical chemistry -- Periodicals
Pharmacology -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4184 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ardp.201300417 ↗
- Languages:
- English
- ISSNs:
- 0365-6233
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1622.800000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3486.xml